In the United States, an estimated 17% of adolescents experienced at least 1 episode of major depression in the past year, and the rate among members of marginalized populations is believed to be significantly higher.
The Innovation and Value Initiative (IVI), a nonprofit research organization committed to advancing the science, practice, and use of value assessment in health care, today announced a collaboration with the University of Southern California Leonard D. Schaeffer Center for Health Policy & Economics to examine treatment patterns and disparities for children and young adults newly diagnosed with major depressive disorder (MDD).
In the United States, an estimated 17% of adolescents experienced at least 1 episode of major depression in the past year, and the rate among members of marginalized populations is believed to be significantly higher. The symptoms of childhood and adolescence depression can include academic decline, withdrawal, unexpected crying, weight changes, and thoughts or actions of self-harm. All too often, depression goes undiagnosed and untreated in this vulnerable population.
Bringing together health policy experts and a seasoned health economics and outcomes research (HEOR) team, this partnership will focus on:
“The USC Schaeffer Center partnership provides a meaningful opportunity to learn how COVID-19 and the broader access to telehealth services has affected health care outcomes and disparities,” noted Rick Chapman, PhD, chief science officer at IVI. “Our goal is to close the gaps and better inform health care outcomes for children and adolescents with major depressive disorder.”
Inside the Center's MDD Value Model and Its Use of Dynamic Pricing
May 13th 2025Larragem Raines, MS, of the Center for Innovation & Value Research, discusses the organization's major depressive disorder (MDD) open-source value model, dynamic pricing, and the future role of artificial intelligence in care.
Listen
Community Oncology Reacts to Trump's Drug Pricing Executive Order
May 2nd 2025An executive order signed on Tuesday, March 15, necessitated a change in plans for this panel discussion from the 2025 Community Oncology Conference, with the assembled experts, moderated by Ted Okon, MBA, executive director of the Community Oncology Alliance, speaking to how the order would reverberate across the community oncology space.
Read More
Advancing the Art of Medicine Through Partnership
April 29th 2025Oncology leaders from Alliance Cancer Specialists, American Oncology Network, CHI St. Vincent, Memorial Sloan Kettering Cancer Center, and New York Cancer & Blood Specialists discussed the power of collaboration in cancer care, highlighting partnerships that enhance patient outcomes and resource sharing in community practices.
Read More